GZMK and neoplasm: Accordingly, CD8+GZMK+ and CD4+GZMK+ T cells are enriched at sites of chronic inflammation in the context of autoimmune diseases and tumors likely contributing to chronicity, tumor immune escape, outgrowth and metastasis.